欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/1630/001
药品名称
Pantoprazol Aurobindo
活性成分
Pantoprazole sodium sesquihydrate 42.3 mg
剂型
Powder for solution for injection
上市许可持有人
Aurobindo Pharma (Portugal), Unipessoal, Lda.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Germany (DE)
Pantoprazol PUREN 40 mg Pulver zur Herstellung einer Injektionslösung
Belgium (BE)
Pantoprazol Eugia 40 mg poeder voor oplossing voor injectie
Netherlands (NL)
Spain (ES)
Italy (IT)
Poland (PL)
Pantoprazole Aurovitas
许可日期
2017/05/10
最近更新日期
2024/11/12
药物ATC编码
A02BC02 pantoprazole
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Labelling
|
common_outer
Date of last change:2024/09/06
Final PL
|
common_pl
Date of last change:2024/09/06
Final SPC
|
common_spc
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase